title: The dormancy dilemma: quiescence versus balanced proliferation.
abstract: Metastatic dissemination with subsequent clinical outgrowth leads to the greatest part of morbidity and mortality from most solid tumors. Even more daunting is that many of these metastatic deposits silently lie undetected, recurring years to decades after primary tumor extirpation by surgery or radiation (termed metastatic dormancy). As primary tumors are frequently curable, a critical focus now turns to preventing the lethal emergence from metastatic dormancy. Current carcinoma treatments include adjuvant therapy intended to kill the cryptic metastatic tumor cells. Because such standard therapies mainly kill cycling cells, this approach carries an implicit assumption that metastatic cells are in the mitogenic cycle. Thus, the pivotal question arises as to whether clinically occult micrometastases survive in a state of balanced proliferation and death, or whether these cells undergo at least long periods of quiescence marked by cell-cycle arrest. The treatment implications are thus obvious--if the carcinoma cells are cycling then therapies should target cycling cells, whereas if cells are quiescent then therapies should either maintain dormancy or be toxic to dormant cells. Because this distinction is paramount to rational therapeutic development and administration, we investigated whether quiescence or balanced proliferation is the most likely etiology underlying metastatic dormancy. We recently published a computer simulation study that determined that balanced proliferation is not the likely driving force and that quiescence most likely participates in metastatic dormancy. As such, a greater emphasis on developing diagnostics and therapeutics for quiescent carcinomas is needed.
authors.affiliation: Department of Pathology and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. wellsa@upmc.edu
authors.forename: Alan
authors.initials: A
authors.lastname: Wells
authors.forename: Linda
authors.initials: L
authors.lastname: Griffith
authors.forename: Jakob Z
authors.initials: JZ
authors.lastname: Wells
authors.forename: Donald P
authors.initials: DP
authors.lastname: Taylor
mesh_terms: D000818:Animals; D019149:Bioreactors; D018929:Cell Culture Techniques; D059447:Cell Cycle Checkpoints; D049109:Cell Proliferation; D003198:Computer Simulation; D006801:Humans; D008954:Models, Biological; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D011379:Prognosis; D014407:Tumor Cells, Cultured